NATIONAL BANK OF CANADA /FI/ - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.

Quarter-by-quarter ownership
NATIONAL BANK OF CANADA /FI/ ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,120
-35.6%
4,000
-20.0%
0.00%
Q2 2023$6,399
+21.2%
5,000
+25.0%
0.00%
Q1 2023$5,280
-12.0%
4,0000.0%0.00%
Q4 2022$6,000
+20.0%
4,0000.0%0.00%
Q3 2022$5,0000.0%4,0000.0%0.00%
Q2 2022$5,000
-58.3%
4,0000.0%0.00%
Q1 2022$12,000
+9.1%
4,0000.0%0.00%
Q4 2021$11,0004,0000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Tamarack Advisers, LP 4,500,000$11,925,0004.90%
HealthInvest Partners AB 1,090,000$2,889,0004.07%
GREAT POINT PARTNERS LLC 5,000,000$13,250,0002.94%
CM Management, LLC 775,000$2,054,0001.55%
SECTOR GAMMA AS 1,469,604$3,894,0000.92%
Sio Capital Management, LLC 913,621$2,421,0000.73%
Telemetry Investments, L.L.C. 190,000$504,0000.65%
DAFNA Capital Management LLC 879,000$2,329,0000.59%
Rock Springs Capital Management LP 4,860,200$12,880,0000.30%
Rhenman & Partners Asset Management AB 1,520,000$4,074,0000.27%
View complete list of RIGEL PHARMACEUTICALS INC shareholders